2021 Annual Report of Hepatoma Research
Thanks to the great effort and contributions made by authors, Editorial Board Members, reviewers, webinar supporters, readers as well as the Editorial Office staff, Hepatoma Research has achieved significant results and progress in the past year. Hereby, we would like to share the development of the journal in 2021 from the following aspects.
1. Editorial Board
As of December 31, 2021, 132 Editorial Board Members joined Hepatoma Research from 18 countries, including the USA, China, Italy, South Korea, Germany, Japan, Singapore, Greece, Spain, Australia, Turkey, the UK, Egypt, Finland, India, Pakistan, Brazil, and Poland.
The Authors of Hepatoma Research in 2021 come from 22 countries and regions.
The Readers of Hepatoma Research range globally, including the United States (26%), India (9%), China (11%), Egypt (5%), the United Kingdom (4%), South Korea (4%), Italy (3%), Pakistan (2%), Thailand (2%) and other 223 countries and regions.
4. Highly Cited Papers
Hepatoma Research published 78 papers in 2021, including 45 reviews, 15 original articles, 6 perspectives, 2 case reports, 1 Technical Note, and 1 Guideline. Here are highly cited papers for recommendation in 2021:
(1) Effect of mesenchymal stem cell in liver regeneration and clinical applications
(2) Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology
(3) Earliest hepatitis B virus-hepatocyte genome integration: sites, mechanism, and significance in carcinogenesis
(4) Beta-catenin activation and immunotherapy resistance in hepatocellular carcinoma: mechanisms and biomarkers
(5) Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
(6) Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma
(7) Immunological characterization of hepatocellular carcinoma
(8) Prevention of hepatitis B virus-related hepatocellular carcinoma
(9) Systematic review of existing guidelines for NAFLD assessment
(10) Patient and port positioning in laparoscopic liver resections
Total article views in 2021: 356,242
Total article downloads in 2021: 67,778
Hepatoma Research held 5 webinars in 2021 focusing on different hot topics:
(1) Surgical Resection for HCC: Insights into the Indications and the Prognosis chaired by Prof. Allan Tsung
(2) Do Standard Toxicology Parameters Match Clinical Needs for Immune Check-point Inhibitors in Liver Cancer Therapy? chaired by Prof.Giuliano Ramadori
(3) Minimally Invasive Surgery for HCC chaired by Prof. Ho-Seong Han
(4) Research on the Risk Factors of Liver Cirrhosis Complicated with HCC chaired by Prof. Guido Gerken
(5) Hepatoma Research Editorial Board Webinar chaired by Prof. Guang-Wen Cao and Prof. Giuliano Ramadori
The journal Hepatoma Research always adheres to publishing more valuable papers and promoting scientific communication and sharing. We would like to express our sincere appreciation to all contributors to Hepatoma Research. We look forward to all your continuous support to help us to build a better journal, and we expect to get more support from scientists and researchers in this research field.